Short Decsription
This product is a β-Galactosidase-targeted RNA modification and metabolomics analysis tool based on the m6A (NSUN4-YTHDF2-TET1/2/3-HDACs-spacer C9) modification and Glycolysis-mediated (FMRP-SAM-NAD+) metabolic analysis system.
Oligonucleotide
2'-OMe, 2'dT (LNP)
RNA Construction
rRNA-m6A-NSUN4-YTHDF2-TET1/2/3-HDACs-spacer C9
Epigenetic regulator
LKB1 deficiency
Metabolic alteration
The formation of an "adenosine rich" suppressive TME
Targeting diseases
Acute Myeloid Leukemia
Metabolic Reprogramming
Glycolysis-FMRP-SAM-NAD+